Psychedelic-assisted therapy - supposedly paradigm-shifting research with poor attempts at hypotheses falsifying and questionable ethics.
作者信息
Tang Bor Luen
机构信息
Department of Biochemistry, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore.
出版信息
EXCLI J. 2024 Dec 2;23:1487-1490. doi: 10.17179/excli2024-8023. eCollection 2024.
Abstract
摘要
相似文献
1
Psychedelic-assisted therapy - supposedly paradigm-shifting research with poor attempts at hypotheses falsifying and questionable ethics.迷幻剂辅助疗法——本应是具有范式转变意义的研究，但在证伪假设方面尝试不足且伦理存疑。
EXCLI J. 2024 Dec 2;23:1487-1490. doi: 10.17179/excli2024-8023. eCollection 2024.
2
Ethical Aspects of Psychedelic-Assisted Treatments: An Overview.迷幻剂辅助治疗的伦理问题：概述
Curr Top Behav Neurosci. 2024 Nov 8. doi: 10.1007/7854_2024_533.
3
Psychedelic-Assisted Group Therapy: A Systematic Review.迷幻辅助团体治疗：系统评价。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):174-188. doi: 10.1080/02791072.2019.1593559. Epub 2019 Apr 5.
4
Giving Consent to the Ineffable.对不可言喻之事表示同意。
Neuroethics. 2024;17(1):11. doi: 10.1007/s12152-024-09545-6. Epub 2024 Feb 15.
5
On the need for metaphysics in psychedelic therapy and research.迷幻疗法与研究中对形而上学的需求
Front Psychol. 2023 Mar 31;14:1128589. doi: 10.3389/fpsyg.2023.1128589. eCollection 2023.
6
Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement.规定意义：关于迷幻剂辅助意义增强疗法使用的享乐主义观点。
J Med Ethics. 2021 Oct;47(10):701-705. doi: 10.1136/medethics-2020-106619. Epub 2020 Nov 4.
7
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.美国国立卫生研究院（NIH）2006 年至 2020 年期间为迷幻辅助治疗临床试验提供的资助。
Int J Drug Policy. 2022 Jan;99:103473. doi: 10.1016/j.drugpo.2021.103473. Epub 2021 Oct 6.
8
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
9
A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.多层次连贯中强化的自我光谱：对迷幻辅助治疗发展挑战的情境行为反应
Front Psychiatry. 2021 Dec 7;12:727572. doi: 10.3389/fpsyt.2021.727572. eCollection 2021.
10
Research abuses against people of colour and other vulnerable groups in early psychedelic research.早期迷幻药研究中针对有色人种和其他弱势群体的研究滥用行为。
J Med Ethics. 2021 Jul 12. doi: 10.1136/medethics-2021-107262.
本文引用的文献
1
MDMA therapy for PTSD rejected by FDA panel.美国食品药品监督管理局专家小组驳回摇头丸治疗创伤后应激障碍的申请。
Nature. 2024 Jun 5. doi: 10.1038/d41586-024-01622-3.
2
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.MDMA 辅助治疗中重度 PTSD：一项随机、安慰剂对照的 3 期试验。
Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14.
3
Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.澳大利亚将在全球率先为创伤后应激障碍（PTSD）和抑郁症患者开具摇头丸和裸盖菇素处方。
Nature. 2023 Jul;619(7969):227-228. doi: 10.1038/d41586-023-02093-8.
4
Neurological and cognitive alterations induced by MDMA in humans.**中文译文**：**人类** **受** **摇头丸** **影响** **的神经** **和认知改变**。
Exp Neurol. 2022 Jan;347:113888. doi: 10.1016/j.expneurol.2021.113888. Epub 2021 Oct 6.
5
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.MDMA 辅助治疗严重 PTSD：一项随机、双盲、安慰剂对照的 3 期研究。
Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10.
Zotero 插件